The results of the present investigation demonstrated that the EGFR/CD3 BsAb significantly enhanced the cytotoxic activity of CIK cells to gastric cancer cells in vitro and in vivo, so this BsAb may potentially aid cellular therapy. This evidence concerns the gene EGFR and gastric cancer.